Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us
Pipeline News and Updates
Picture

New Aminoglycoside May Be Approved In June

6/18/2018

 
It may seem surprising, but Achaogen is developing a new aminogycoside for the treatment of multi-drug resistant bacteria, including carbopenem resistant bacteria.  Achaogen filed an NDA in Oct 2017. In May, an FDA Advisory Committee voted 15-0 to recommend approval of plazomicin for the treatment of complicated UTI, but voted against recommending approval of the drug for bacteremia (4-11 to approve).

Achaogen announced  that plazomicin was found to be non-inferior  to meropenem for complicated UTI in a 609 patient, Phase III, EPIC trial. The drug also demonstrated lower mortality and complication rate than colestin in Phase III, CARE trial that enrolled 69 patients with carbapenem-resistant enterobacteriaceae bacteremia that were receiving meropenem or tigecycline. The original study was to include a cohort of patients with hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP), but due to problems in recruiting patients, the bacteremia cohort was combined with the HABP/VABP.  With the lower patient population, no statistical analysis was possible.  

Current trial data display no significant safety concerns; no independent safety data are yet available. The most common ADR reported in trials are diarrhea, hypertension, headache, nausea, and vomiting. In a review the FDA concluded that transient nephrotoxicity was seen in trials. While the sample size of the bacteremia trial was too small to determine if there was less nephrotoxicity than colistin, there was a trend in that direction. There was no ototoxicity found in studies, but the FDA did not feel the evidence of definitive. 

Researchers at Hartford Hospital, examined the compatibility of plazomicin with 92 drugs in a simulated Y-site administration test. Plazomicin was compatible with 79 of the drugs (31 antibiotics) and incompatible with 13.

Plazomicin has a PDUFA date of June 25, so we will likely see the first new aminoglycoside in decades be approved.

Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    January 2023
    December 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.